Loading...
NYSE: DHR
Danaher Corporation
Healthcare · Medical - Diagnostics & Research
●S&P 500 since 1998
Market Cap
$135.42B
52w High
$242.80
52w Low
$171.00
P/E
37.48
Volume
4.12M
Outstanding Shares
707.14M
Company profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
CEORainer Blair
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees61,000
IPO dateDec 29, 1978
Valuation
Forward P/E—
EV/EBITDA25.30
Enterprise value$175.72B
Stock splits
Oct 2, 2023141:125
Jul 5, 20161319:1000
Jun 14, 20102:1
May 21, 20042:1
Jun 1, 19982:1
Jan 23, 19952:1
Sep 9, 19872:1
Profitability & growth
Revenue growth4.59%
Gross margin60.93%▲2.41%vs FY2024
Operating margin20.91%▼3.70%vs FY2024
ROE6.88%▼12.59%vs FY2024
Analyst consensus
RatingBuy
Target price$253.75▲32.51%
31
Buy
10
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 28, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$1.80
$1.64
Q3FY25
ActualEst.
$1.89
$1.72
Q4FY25
ActualEst.
$2.23
$2.16
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$5.94B
$5.84B
Q3FY25
ActualEst.
$6.05B
$6B
Q4FY25
ActualEst.
$6.84B
$6.81B
Q1FY26
Next Est.
—